New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
April 30, 2014
07:46 EDTNBSNeoStem subsidiary enters into services agreement with IRX Therapeutics
NeoStem and its subsidiary, Progenitor Cell Therapy, announced the execution of a Services Agreement with IRX Therapeutics, under which PCT will provide services to support IRX's development of IRX-2, a primary cell-derived biologic with multiple active cytokine components. IRX-2 is a cancer therapeutic designed to activate a patient's immune system to broadly restore immunity and overcome cancer-induced immune suppression. IRX has engaged PCT for the manufacture of an intermediate component referred to as IRX-2 Drug Substance for human clinical trials.
News For NBS From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
May 26, 2015
07:33 EDTNBSNeoStem appoints Merrick Ross as lead for NeoStem's Intus study
Subscribe for More Information
May 21, 2015
15:19 EDTNBSNeoStem spikes higher, levels to watch
The shares are spiking sharply, last up more than 45% to $3.30. At that price next resistance is at the session high at $3.47 and then at $3.71. Support is at $3.17.
15:17 EDTNBSNeoStem up over 40% after getting $17.7M grant for metastatic melanoma treatment
Subscribe for More Information
15:15 EDTNBSNeoStem gets $17.7M grant for metastatic melanoma treatment
Subscribe for More Information
15:11 EDTNBSNeoStem gets $17.7M grant from CIRM

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use